HIPAA Alert: Potential Data Breach Learn More

Close this search box.
Niloo Prasad, MD

Niloo Prasad, MD

Board Certifications: Internal Medicine and Medical Oncology

Languages: English and Hindi

Locations: Edison, NJ

Dr. Niloo Prasad is an oncology and hematology specialist practicing in Edison, N.J. She grew up in both India and England before immigrating to the United States. She received her medical degree from Nalanda Medical College and has been in practice for more than 25 years.

Dr. Prasad did her residency training in Internal Medicine at Grant Hospital in Chicago, and her fellowship in Hematology and Oncology at the prestigious NYU Langone Cancer Center. As part of her training, she worked at the Manhattan VA Medical Center, where she treated many veterans with cancer and blood disorders.

Dr. Prasad served on the clinical faculty at Raritan Bay Medical Center and participated in educational programs for residents, as well as medical students. She gained initial board certification in internal medicine and medical oncology through the American Board of Internal Medicine (ABIM), and now maintains certification through the National Board of Physicians and Surgeons (NBPAS).


Medical Education

Nalanda Medical College, Bihar, India


Grant Hospital, Chicago, Ill. (Internal Medicine)


NYU Langone Medical Center, N.Y. (Medical Oncology)

Awards and honors

Awards and honors

  • NJ Top Doctors

Professional Memberships

  • American Society of Clinical Oncology
  • American Medical Association
  • American Association of Physicians of Indian Origin

Hospital Affiliations

JFK Medical Center, Edison, N.J.
Robert Wood Johnson University Hospital, Rahway, N.J.

we are here for you

For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.

Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.